Norris Perne & French’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
KFO
Norris Perne & French's NEO Position: Q1 2022 in Review
Norris Perne & French sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 221,424 shares — an estimated $7.55M sold.
Norris Perne & French first reported a position in NEO in Q3 2018 and held it in 14 quarters. The position peaked at $14.1M in Q2 2020. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Norris Perne & French reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
- Norris Perne & French sold 221,424 NeoGenomics shares in Q1 2022, an estimated $7.55M.
- Norris Perne & French first reported a position in NeoGenomics in Q3 2018 and held it in 14 quarters.
- Norris Perne & French's NeoGenomics position peaked at $14.1M in Q2 2020.
- 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Norris Perne & French's 13F filing for Q1 2022, filed 26 Apr 2022.